Credit Suisse Starts PetMed Express (PETS) at Underperform, $13 PT

Credit Suisse initiates coverage on PetMed Express (NASDAQ: PETS) with a Underperform rating and a price target of $13.00.

Analyst E. Wilson commented, "We Are Initiating Coverage of PETS with an Underperform Rating and a $13 Target Price: An increasingly competitive market with multiple structural challenges limit PETS's revenue and EPS growth over the near- and longer-term."

For an analyst ratings summary and ratings history on PetMed Express click here. For more ratings news on PetMed Express click here.

Shares of PetMed Express closed at $17.17 yesterday.

You May Also Be Interested In

• Raymond James Starts Southern California Bancorp (BCAL) at Outperform
• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility